Deakin University
Browse

File(s) under embargo

Amyloid beta 42 alters cardiac metabolism and impairs cardiac function in male mice with obesity

Version 3 2024-06-19, 23:22
Version 2 2024-06-03, 02:39
Version 1 2024-04-19, 03:41
journal contribution
posted on 2024-06-19, 23:22 authored by LG Hall, JK Czeczor, Timothy ConnorTimothy Connor, J Botella, KA De Jong, MC Renton, AJ Genders, K Venardos, SD Martin, ST Bond, Kathryn Aston-MourneyKathryn Aston-Mourney, Kirsten HowlettKirsten Howlett, JA Campbell, GR Collier, Ken WalderKen Walder, Matthew McKenzieMatthew McKenzie, Mark ZiemannMark Ziemann, Sean McgeeSean Mcgee
AbstractThere are epidemiological associations between obesity and type 2 diabetes, cardiovascular disease and Alzheimer’s disease. The role of amyloid beta 42 (Aβ42) in these diverse chronic diseases is obscure. Here we show that adipose tissue releases Aβ42, which is increased from adipose tissue of male mice with obesity and is associated with higher plasma Aβ42. Increasing circulating Aβ42 levels in male mice without obesity has no effect on systemic glucose homeostasis but has obesity-like effects on the heart, including reduced cardiac glucose clearance and impaired cardiac function. The closely related Aβ40 isoform does not have these same effects on the heart. Administration of an Aβ-neutralising antibody prevents obesity-induced cardiac dysfunction and hypertrophy. Furthermore, Aβ-neutralising antibody administration in established obesity prevents further deterioration of cardiac function. Multi-contrast transcriptomic analyses reveal that Aβ42 impacts pathways of mitochondrial metabolism and exposure of cardiomyocytes to Aβ42 inhibits mitochondrial complex I. These data reveal a role for systemic Aβ42 in the development of cardiac disease in obesity and suggest that therapeutics designed for Alzheimer’s disease could be effective in combating obesity-induced heart failure.

History

Journal

Nature Communications

Volume

15

Article number

258

Pagination

1-13

Location

London, Eng.

ISSN

2041-1723

eISSN

2041-1723

Language

eng

Publication classification

C1 Refereed article in a scholarly journal

Issue

1

Publisher

Nature Research (part of Springer Nature)

Usage metrics

    Research Publications

    Categories

    No categories selected

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC